Reagent-free determination of amikacin content in amikacin sulfate injections by FTIR derivative spectroscopy in a continuous flow system  by Ovalles, José F. et al.
Contents lists available at ScienceDirect
www.elsevier.com/locate/jpa
Journal of Pharmaceutical Analysis
Journal of Pharmaceutical Analysis 2014;4(2):125–1312095-1779 & 2013 Xi
http://dx.doi.org/10.10
nCorresponding aut
E-mail address: ov
Peer review under rwww.sciencedirect.comORIGINAL ARTICLE
Reagent-free determination of amikacin content
in amikacin sulfate injections by FTIR derivative
spectroscopy in a continuous ﬂow systemJosé F. Ovallesa,n, Máximo Gallignanib, María R. Brunettob, Rebeca A. Rondónb,
Carlos AyalabaDepartamento de Análisis y Control, Facultad de Farmacia y Bioanálisis, Universidad de Los Andes, Mérida 5101A, Venezuela
bLaboratorio de Espectroscopia Molecular, Departamento de Química, Facultad de Ciencias, Universidad de Los Andes, Mérida 5101A,
Venezuela
Received 14 February 2013; accepted 6 August 2013
Available online 14 August 2013KEYWORDS
Amikacin;
FTIR derivative spectro-
metry;
Continuous ﬂow system;
Pharmaceutical
preparation;
Injection;
Sulfate’an Jiaotong Univer
16/j.jpha.2013.08.00
hor. Tel.: þ58 274 2
allesd@ula.ve (J.F.
esponsibility of Xi'aAbstract The quantitative estimation of amikacin (AMK) in AMK sulfate injection samples is reported
using FTIR-derivative spectrometric method in a continuous ﬂow system. Fourier transform of mid-IR
spectra were recorded without any sample pretreatment. A good linear calibration (r40.999, %RSDo
2.0) in the range of 7.7–77.0 mg/mL was found. The results showed a good correlation with the
manufacturer's and overall they all fell within acceptable limits of most pharmacopoeial monographs on
AMK sulfate.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Amikacin (AMK) is used to treat infections caused by Gram-negative
bacteria. It is a semi-synthetic aminoglycoside derived fromsity. Production and hosting by Elsev
1
449145; fax: þ58 274 2403464.
Ovalles).
n Jiaotong University.kanamycin, formulated as a disulfate salt (Fig. 1). The dosage form
is normally supplied as a sterile solution for parenteral use [1].
Aminoglycoside antibiotics determination has been carried out by
a wide variety of methods [2–4]. However, a direct UV–vis spectro-
photometric estimation is not feasible [5]. The former Pharmacopoeia
of United States (USP 24) [6] and later the European Pharmacopoeia
(Ph. Eur. 6) [7] and British Pharmacopoeia (BP) [8] reported
derivatization procedures of AMK prior to reversed-phase liquid
chromatographic (LC) analysis. As it is too time consuming, LC
methods based on non-derivatization procedures, such as universal
aerosol-based detector [9], ligand displacement reaction [10], charged
aerosol [11], evaporative light scattering [12] and resonance Rayleighier B.V. All rights reserved.
Fig. 1 FTIR spectra of the AMK sulfate injections related substances. Excipients constituted by water, 1.3 mg/mL sodium bisulﬁte, and 5 mg/mL
sodium citrate (a). Aqueous sulfuric acid solution, pH¼4.5 (b). AMK sulfate standard (50 mg/mL) as AMK base (c). All spectra were obtained
using water background.
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detection method [14–16] has been adopted in the recent USP
monograph [1]. The major drawback of the detection approach
coupled to LC is that it requires skills for implementation [17].
Pharmaceutical raw materials are also tested for sulfate content
[18]. The actual pharmacopoeial monographs, Eur. Ph. [7] and USP
[1] refer to sulfate counter-ion content as a molar ratio between AMK
and H2SO4. The sulfate ion, outside the allowed range, could indicate
that AMK is present as a free base or the sulfate ion, in excess, is
present as an impurity [19]. Recently, our research group proposed a
Fourier-transform infrared (FTIR) method for determining the sulfate
counter-ion content in AMK sulfate injections [19].
FT-mid-IR in conjunction with a continuous ﬂow system (CFS)
was extensively used for quantitative estimation of active ingredients
in pharmaceutical preparations [19–28]. The spectrum is a marker for
identity and purity of the active pharmaceutical ingredient (API) and
also useful to detect impurities coming from the excipients.
A direct reagent-free determination of AMK content in parenteral
formulations of AMK sulfate by CFS-FTIR-derivative spectrometry
(DS) is proposed keeping in view principles of green analytical
chemistry [19,29–32]. The advantage of the present method is to
simultaneously quantify AMK base and sulfate counter-ion in AMK
sulfate injections with a single spectrum.
2. Experimental
2.1. Reagents and samples
All chemicals used were of analytical-reagent grade. Water was
obtained from a Milli-Q-TOC puriﬁcation system (Millipore, Bedford,
MA, USA). Reference standards: AMK sulfate stating 786 μg/mg as
AMK base, purchased from Sigma-Aldrich (St Louis, MO, USA) and
AMK sulfate with 99.95% purity, kindly provided by a pharmaceutical
manufacturer of the region. Standard stock solution of AMK sulfate
(100 mg/mL) was prepared in water. Pharmaceutical products were
acquired from local drug stores and analyzed directly from the
ampoules. Commercial samples containing a concentration higher than
50 mg/mL of AMK base were diluted with water to obtain required
concentrations.
2.2. Apparatus
A Perkin–Elmer, model Spectrum 2000, FTIR spectrophotometer
(Norwalk, CT, USA) was employed for acquisition of spectra.The FTIR equipment was connected to a monochannel ﬂow
system through a ﬂow cell. A demountable liquid transmission
cell (Wilmad Labglass, Buena, NJ, USA) with ZnSe windows
(38 mm 19 mm size, 2 mm thick, and 0.05 mm optical path-
length) was used. An Ismatec IPC peristaltic pump (Glattbrugg,
Switzerland) equipped with Tygon tubing was employed for
sample and standard propulsion. A Rheodyne manual selecting
valve (Alltech, Waukegan, USA) was used for carrying either
sample solution or standard solution into the ﬂow cell.
2.3. General procedure
A schematic diagram of the continuous ﬂow system and its operation
steps were presented earlier [27]. The system was optimized for leaks,
air bubbles, and pump ﬂow rate. Calibration or test sample solutions
were continuously pumped in order to reach the ﬂow cell. An
injection valve was switched to the solution in turn. The continuous
ﬂowing stream of either samples or standards was monitored using
the FTIR spectrometer. Each spectrum was automatically converted
to its ﬁrst-order derivative spectrum. The validation of the analytical
method was carried out as it was described by us earlier [19].3. Results and discussion
3.1. Identiﬁcation, FTIR spectra of AMK sulfate and related
excipients in aqueous phase
Infrared spectra of API were recorded under the optimum instru-
mental conditions. We can see that water showed the characteristic
transparency zone localized close to the ﬁngerprint region 1600–
900 cm1 (Fig. 1). AMK sulfate has two absorption bands, one broad
and intense band observed in the range of 1220–938 cm1 with a
maximum at 1100 cm1, and the other, with lesser intensity in the
range of 1590–1480 cm1 with a maximum at 1538 cm1. The
spectra also show that the presence of excipients, at the stated
concentrations in the formulation, do not have any additional IR
bands in the ﬁngerprint region, except the sulfate from sulfuric acid.
3.2. Selection of the analytical spectral band
and the analytical measurement criterion
The two mid-IR bands of AMK sulfate are due to contribution
of carbohydrate moiety and hetero-oxy groups of the sulfate
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1480 cm1 arises from the aminoglycoside moiety [19]. In the
present study, the latter spectral band was selected for further
studies. This band was evaluated using DS to overcome spectral
deviations and to choose the best analytical performance of the
proposed FTIR method (Fig. 2). The ﬁrst-order derivative locates
the spectral region where minimal bandshape spectral variability
was observed, both from inter sample variation and compared to
the standard. Further, higher order derivatives of the AMK
spectrum for different samples were evaluated. Considering the
little advantage of using higher order derivative spectra, only ﬁrst
order derivative was selected for further studies.
In order to choose the best analytical performance of the FTIR-
DS determination of AMK in parenteral pharmaceutical formula-
tions, different measurement criteria were evaluated (Table 1). As
a compromise among sensitivity, precision, and band shape, the
selected measurement criterion for determining AMK content was
the peak area under the baseline in the range of 1538–1469 cm1
(Fig. 2B). A derivative-window of 25 points was selected for
analytical purposes.
3.3. Effect of instrumental and experimental conditions
In this regard, the selected spectral analytical signal was evaluated
by changing one variable at a time, each by triplicate, using
solutions containing 50 mg/mL of AMK base. Accordingly, a
nominal resolution of 4 cm1, by accumulating 5 scans, was
selected for analytical purposes as a compromise to the smoothness
of bandshape, precision (o2% RSD) and spectral acquisition timeFig. 2 The zeroth (A) and ﬁrst (B) derivative spectra of representative
solutions. Each analyzed solution with a nominal concentration of 50 m
concentration units in mg for 2 mL pharmaceutical products.(o30 s). The latter data and those obtained for the CFS parameters,
such as ﬂow rate (0.3 mL/min) and sample analysis frequency
(13 h1), were consistent with those obtained from our earlier work
[19]. As depicted in Fig. 3, there was very minimal ﬂuctuation on
the analytical signal as a function of pH values between 3.0 and 5.5,
where precision was better than the percentage unit.
3.4. Analytical ﬁgures of merit of the CFS-FTIR-DS method
Validation of the analytical method was performed to demonstrate its
usefulness in the direct determination of AMK content in AMK
sulfate injections. Corrected peak-area of the ﬁrst order DS was used
for obtaining the regression line (Table 1). Eight concentrations
ranging from 7.7 mg/mL to 77.0 mg/mL (AMK base) were used to
obtain the calibration curve. A straight line with an excellent
correlation coefﬁcient (40.999) with negligible deviations from
linearity at low and high concentrations was obtained. The limit of
detection ((3s(1/slope)) and the limit of quantiﬁcation (10s(1/slope))
were sufﬁcient for analysis of parenteral formulations (Table 1).
The scatter in the results due to the instrumental variability was
1.4% (RSD, n¼10). Intra-assay precision was less than 2% (RSD,
n¼6). The precision of the accuracy was assessed using a linear
response function at three concentrations covering the range. The
observed RSD ranged from 0.40% to 1.44%.
The robustness of the method was considered to be appropriate
during normal usage because common parameters affecting other
methods were not involved in the present proposal. The effect of
pH variability of the sample solutions on the response signal was
negligible in the range (3.5–5.5) stated by the USP (Fig. 3).commercial AMK sulfate injections against two reference standard
g/mL AMK base. In Fig. 2A, 100 and 250 represent the declared
J.F. Ovalles et al.128Speciﬁcity research was conducted during the preliminary studies.
As depicted in Fig. 1, the interferences study of coexisting foreign
inorganic ions and organic compounds revealed no interference on
the selected spectral region for quantization purposes. Background
and baseline displacement that use to affect the intercept of a
calibration function, but not its slope, was previously corrected by
DS selecting the appropriate band wavenumber range. The IR
spectroscopy studies revealed no apparent difference between the
standard spectrum and the sample spectra (Fig. 2). Similarly, in
spite of any disparity in the concentration, the latter studies
revealed no apparent change in bandshape from sample to sample.
These parameters and the satisfactory results could somehow
assure the accuracy of the method. Nevertheless, we carried out a
recovery experiment. On the average, recoveries were within 97%
and 103%, which is similar to or better than recoveries obtained by
using other much more complicated methodologies (Table 2).Table 1 Analytical results obtained for determining AMK base co
method.
Band peak parameters (units in cm1) of the ﬁrst derivative spectra
Measurement mode Location Baseline
Total height 1514 Zero abs
Corrected height 1514 1538–1469
Total area 1514 Zero abs
Corrected area 1514 1538–1469
aCalibration curves obtained using eight standards of AMK sulfate, in trip
to 77.0 (mg/mL); where X is the explanatory variable and Y is the dependent
deviation; r¼correlation coefﬁcient; LOD¼ limit of detection in mg/mL AM
Fig. 3 Effect of the pH value of the sample solution on both signal inte
criterion. The study was carried out using an AMK sulfate standard equiv
Table 2 Representative recovery of AMK base added to AMK sulf
Type of drug brand AMK base (mg/mL7SD) (n¼3) Re
Endogenous Added Found
Innovator A 11.870.6 23.08 35.470.4 10
38.46 49.370.2 9
46.15 57.070.3 9
Brand A 11.370.2 23.08 34.670.5 10
38.46 49.970.3 10
46.15 57.670.4 103.5. Application to pharmaceutical preparations
Finally, validation of the proposed methodology was carried out by
its application to pharmaceutical preparations. The results obtained
for determining AMK content in AMK sulfate injections by
interpolation in the external calibration were in acceptable agreement
with the nominal content claimed by the pharmaceutical manufac-
turers (Table 3). Moreover, all the obtained values for the commercial
samples were within the limits of ofﬁcial pharmacopoeias.
3.5.1. Applicability of the method in the simultaneous
quantitation of AMK base and sulfate counter-ion
in AMK sulfate injections
Fig. 4 shows the viability of simultaneously measuring AMK base
and sulfate counter-ion in AMK sulfate injections with one spectrum.ntent in AMK sulfate injections by the proposed CFS-FTIR-DS
Parameters derived from linear regressiona: Y¼aþbX
a7SD ( 103) b7SD ( 103) r LOD RSD
0.0870.02 0.064870.0004 0.9996 2.1 0.004
0.0570.07 0.072870.0007 0.9995 2.2 0.005
171 2.2570.02 0.9987 3.5 0.30
1.070.6 2.8170.01 0.9997 1.6 0.15
licate, registered as its equivalent AMK concentration ranging from 7.7
variable; the slope of the line is b, and a is the Y-intercept; SD¼standard
K base calculated as 3s(1/slope); RSD¼relative standard deviation (%).
nsity and spectral band shape according to the selected measurement
alent to 50 mg/mL AMK base and water as background.
ate injections.
covery (%) Standard addition calibration: Y¼aþbX r
2.4 Y¼0.034 1þ0.002 79X 0.999
7.7
7.9
0.8 Y¼0.032 8þ0.002 81X 0.999
0.3
0.1
Table 3 Analytical application of the proposed CFS-FTIR-DS method for determining AMK base content in AMK sulfate injections.
Sample
(Lot)
Type of
branded
drug a
Concentration per ampoule of AMK base Acceptance criterion
Claimed Claimed
(mg/mL)
Actual result
7SDb (mg/mL)
(90.0–110.0)
% BP
Pass/
Fail
(90.0–120.0) %
USP and Ph. Int.
Pass/
Fail
S1(A–D) Brand A 100 mg/2 mL 50 5072 45–55 Pass 45–60 Pass
S2 Innovator A 100 mg/2 mL 50 5571 45–55 Pass 45–60 Pass
S3 Brand B 100 mg/2 mL 50 49.870.6 45–55 Pass 45–60 Pass
S4 Generic B 100 mg/2 mL 50 5071 45–55 Pass 45–60 Pass
S5 Generic A 250 mg/2 mL 125 12272 112.5–137.5 Pass 112.5–150.0 Pass
S6 Brand A 500 mg/2 mL 250 25674 225–275 Pass 225–300 Pass
S7(A-D) Brand A 500 mg/2 mL 250 239710 225–275 Pass 225–300 Pass
S8 Brand B 500 mg/2 mL 250 251.070.4 225–275 Pass 225–300 Pass
S9 Generic B 500 mg/2 mL 250 25272 225–275 Pass 225–300 Pass
S10 Innovator B 1000 mg/
4 mL
250 23673 225–275 Pass 225–300 Pass
aBrand, available from one or more manufacturers, distributors, and/or re-packagers by generic (nonproprietary) name; innovator “B” was
manufactured by a foreign country; S1(A–D) and S7(A–D) mean parenteral products from different lots.
bSD, standard deviation (n¼3). The mean and the standard deviation of S1 and S7 belong to a set of lot data, each also analyzed by triplicate. BP,
British Pharmacopoeia. USP, United States Pharmacopoeia. Ph. Int., The International Pharmacopoeia.
Fig. 4 Proposal for simultaneously determining the content of both AMK free base and sulfate counter-ion in AMK sulfate injections. Zeroth
order spectra (A). First order spectra (B). The calibration curve was constructed with AMK sulfate standards at concentrations of 0, 20, 40, 60, 80
and 100 mg/mL (a)-(f). The left hand insert shows additionally a spectrum of a representative pharmaceutical sample with a nominal
concentration of 50 mg/mL AMK base. The right hand insert shows how the AMK carbohydrate moiety does not interfere in the determination of
sulfate counter-ion (discontinuous line).
Quantitative estimation of amikacin from pharmaceutical dosage form by CFS-FTIR spectrometry 129The two major spectral bands were monitored simultaneously. The
possibility of measuring sulfate counter-ion in the presence of the
AMK moiety in the spectral range, where carbohydrates present
strong IR absorption, was discussed earlier by us [19].4. Conclusion
The determination of active content of compounds in pharmaceu-
tical preparations of AMK sulfate is often achieved by HPLC with
J.F. Ovalles et al.130electrochemical detection or pre-column derivatization. In this
paper, we reported a simple, precise, and accurate methodology for
the CFS-FTIR-DS determination of AMK content in aqueous
AMK sulfate injections. The actual proposal is based on direct
measurements of untreated samples. This green analytical method
is an alternative to those that employ separating techniques
coupled with either uncommon detection modes or those requiring
derivatization procedures.
Since sulfate content is also subject to control as mandated in
the pharmacopoeias, one of the strengths of the proposal is that the
assay for AMK in AMK sulfate injections can be employed
simultaneously to determine the sulfate counter-ion by monitoring
two different spectral bands in just one spectrum. Therefore, the
proposed CFS-FTIR-DS strategy represents a promising tool for
characterizing the quality of both bulk drug materials and
pharmaceutical formulations containing AMK sulfate. In addition,
it can signiﬁcantly reduce both expensive laboratory analysis and
chemical waste.
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